Objectives:

1. Compare and contrast germline genetic testing and somatic genetic testing for utilization in cancer patients.
2. Identify patients that are eligible for germline genetic evaluation, both before and after somatic results are known.
3. Improve patient understanding and consenting for different types of genetic testing.

Zoom info:

Join from a PC, Mac, iPad, iPhone or Android device:

    Please click this URL to join. https://uwmadison.zoom.us/s/91623359899?pwd=T0xBVEVmVXMxa2NYRUhBV1FtMTFkdz09

    Passcode: Grand

Or One tap mobile:

    +19292056099,,91623359899# US (New York); +13017158592,,91623359899# US (Washington DC)

Or join by phone:

    Dial(for higher quality, dial a number based on your current location):

        US: +1 929 205 6099  or +1 301 715 8592  or +1 305 224 1968  or +1 309 205 3325  or +1 312 626 6799  or +1 646 931 3860  or +1 564 217 2000  or +1 669 444 9171  or +1 669 900 6833  or +1 689 278 1000  or +1 719 359 4580  or +1 253 205 0468  or +1 253 215 8782  or +1 346 248 7799  or +1 360 209 5623  or +1 386 347 5053  or +1 507 473 4847

    Webinar ID: 916 2335 9899; International numbers available: https://uwmadison.zoom.us/u/azM6ND4bH

Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East); Webinar ID: 916 2335 9899; Passcode: 376527

SIP: 91623359899@zoomcrc.com; Passcode: 376527